Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290674393> ?p ?o ?g. }
- W4290674393 endingPage "e063784" @default.
- W4290674393 startingPage "e063784" @default.
- W4290674393 abstract "Penicillin allergies are highly prevalent in the healthcare setting and associated with the prescription of second-line inferior antibiotics. More than 85% of all penicillin allergy labels can be removed by skin testing and 96%-99% of low-risk penicillin allergy labels can be removed by direct oral challenge. An internally and externally validated clinical assessment tool for penicillin allergy, PEN-FAST, can identify a low-risk penicillin allergy without the need for skin testing; a score of less than 3 has a negative predictive value of 96.3% (95% CI, 94.1 to 97.8) for the presence of a penicillin allergy. It is hypothesised that PEN-FAST is a safe and effective tool for assessing penicillin allergy in an outpatient clinic setting.This is an international, multicentre randomised control trial using the PEN-FAST tool to risk-stratify penicillin allergy labels in adult outpatients. The study's primary objective is to evaluate the non-inferiority of using PEN-FAST score-guided management with direct oral challenge compared with standard care (defined as prick and intradermal skin testing followed by oral penicillin challenge). Participants will be randomised 1:1 to the intervention arm (direct oral penicillin challenge) or standard of care arm (skin testing followed by oral penicillin challenge, if skin testing is negative). The sample size of 380 randomised patients (190 per treatment arm) is required to demonstrate non-inferiority.The study will be performed according to the guidelines of the Helsinki Declaration and is approved by the Austin Health Human Research Ethics Committee (HREC/62425/Austin-2020) in Melbourne Australia, Vanderbilt University Institutional Review Board (IRB #202174) in Tennessee, USA, Duke University Institutional Review Board (IRB #Pro00108461) in North Carolina, USA and McGill University Health Centre Research Ethics Board in Canada (PALACE/2022-7605). The results of this study will be published and presented in various scientific forums.NCT04454229." @default.
- W4290674393 created "2022-08-08" @default.
- W4290674393 creator A5018729944 @default.
- W4290674393 creator A5028884287 @default.
- W4290674393 creator A5038304654 @default.
- W4290674393 creator A5041525318 @default.
- W4290674393 creator A5051366201 @default.
- W4290674393 creator A5076959994 @default.
- W4290674393 creator A5077775016 @default.
- W4290674393 creator A5080985934 @default.
- W4290674393 creator A5083970705 @default.
- W4290674393 creator A5085741718 @default.
- W4290674393 date "2022-08-01" @default.
- W4290674393 modified "2023-10-14" @default.
- W4290674393 title "Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol" @default.
- W4290674393 cites W2054889338 @default.
- W4290674393 cites W2286634806 @default.
- W4290674393 cites W2340695316 @default.
- W4290674393 cites W2460535265 @default.
- W4290674393 cites W2574527709 @default.
- W4290674393 cites W2597552353 @default.
- W4290674393 cites W2615507425 @default.
- W4290674393 cites W2783864925 @default.
- W4290674393 cites W2810697168 @default.
- W4290674393 cites W2897414178 @default.
- W4290674393 cites W2900591766 @default.
- W4290674393 cites W2904279714 @default.
- W4290674393 cites W2906397979 @default.
- W4290674393 cites W2948186518 @default.
- W4290674393 cites W2979924004 @default.
- W4290674393 cites W3006754325 @default.
- W4290674393 cites W3012112115 @default.
- W4290674393 cites W3027730910 @default.
- W4290674393 cites W3044684332 @default.
- W4290674393 cites W4210683513 @default.
- W4290674393 cites W4292528167 @default.
- W4290674393 doi "https://doi.org/10.1136/bmjopen-2022-063784" @default.
- W4290674393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35940831" @default.
- W4290674393 hasPublicationYear "2022" @default.
- W4290674393 type Work @default.
- W4290674393 citedByCount "5" @default.
- W4290674393 countsByYear W42906743932023 @default.
- W4290674393 crossrefType "journal-article" @default.
- W4290674393 hasAuthorship W4290674393A5018729944 @default.
- W4290674393 hasAuthorship W4290674393A5028884287 @default.
- W4290674393 hasAuthorship W4290674393A5038304654 @default.
- W4290674393 hasAuthorship W4290674393A5041525318 @default.
- W4290674393 hasAuthorship W4290674393A5051366201 @default.
- W4290674393 hasAuthorship W4290674393A5076959994 @default.
- W4290674393 hasAuthorship W4290674393A5077775016 @default.
- W4290674393 hasAuthorship W4290674393A5080985934 @default.
- W4290674393 hasAuthorship W4290674393A5083970705 @default.
- W4290674393 hasAuthorship W4290674393A5085741718 @default.
- W4290674393 hasBestOaLocation W42906743931 @default.
- W4290674393 hasConcept C110586980 @default.
- W4290674393 hasConcept C126322002 @default.
- W4290674393 hasConcept C142724271 @default.
- W4290674393 hasConcept C168563851 @default.
- W4290674393 hasConcept C174802600 @default.
- W4290674393 hasConcept C177713679 @default.
- W4290674393 hasConcept C187212893 @default.
- W4290674393 hasConcept C203014093 @default.
- W4290674393 hasConcept C204787440 @default.
- W4290674393 hasConcept C207480886 @default.
- W4290674393 hasConcept C2426938 @default.
- W4290674393 hasConcept C2780385302 @default.
- W4290674393 hasConcept C2908647359 @default.
- W4290674393 hasConcept C2910117706 @default.
- W4290674393 hasConcept C3020110884 @default.
- W4290674393 hasConcept C501593827 @default.
- W4290674393 hasConcept C71924100 @default.
- W4290674393 hasConcept C86803240 @default.
- W4290674393 hasConcept C89423630 @default.
- W4290674393 hasConcept C98274493 @default.
- W4290674393 hasConcept C99454951 @default.
- W4290674393 hasConceptScore W4290674393C110586980 @default.
- W4290674393 hasConceptScore W4290674393C126322002 @default.
- W4290674393 hasConceptScore W4290674393C142724271 @default.
- W4290674393 hasConceptScore W4290674393C168563851 @default.
- W4290674393 hasConceptScore W4290674393C174802600 @default.
- W4290674393 hasConceptScore W4290674393C177713679 @default.
- W4290674393 hasConceptScore W4290674393C187212893 @default.
- W4290674393 hasConceptScore W4290674393C203014093 @default.
- W4290674393 hasConceptScore W4290674393C204787440 @default.
- W4290674393 hasConceptScore W4290674393C207480886 @default.
- W4290674393 hasConceptScore W4290674393C2426938 @default.
- W4290674393 hasConceptScore W4290674393C2780385302 @default.
- W4290674393 hasConceptScore W4290674393C2908647359 @default.
- W4290674393 hasConceptScore W4290674393C2910117706 @default.
- W4290674393 hasConceptScore W4290674393C3020110884 @default.
- W4290674393 hasConceptScore W4290674393C501593827 @default.
- W4290674393 hasConceptScore W4290674393C71924100 @default.
- W4290674393 hasConceptScore W4290674393C86803240 @default.
- W4290674393 hasConceptScore W4290674393C89423630 @default.
- W4290674393 hasConceptScore W4290674393C98274493 @default.
- W4290674393 hasConceptScore W4290674393C99454951 @default.
- W4290674393 hasFunder F4320313298 @default.
- W4290674393 hasIssue "8" @default.